LACY TANGEDAHL: Open Payments
NPI 1942501861 · BILLINGS, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$319 in 8 payments from 5 companies in 2025. Trend: 2023 $308 · 2024 $592 · 2025 $319
Education: $190Food & beverage: $129
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $190 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
| Merck Sharp & Dohme LLC | 2 | $48 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: KEYTRUDA, FRUZAQLA, ADVATE, JEMPERLI, KISQALI.
Industry payments across MT — which companies pay providers there.
